Alpha-9 Oncology
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company based in Cambridge, USA, and Vancouver, Canada, founded in 2020. The company develops highly selective and potent targeted radiotherapies for cancer through a bespoke, iterative engineering process. Its platform optimizes all components of the radiopharmaceutical molecule—binder, linker, chelator, and radioisotope—to deliver precise radiation to tumor cells.
Radiopharmaceuticals